- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02933008
Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality
September 11, 2024 updated by: Greg Myer, Emory University
Traumatic, debilitating anterior cruciate ligament (ACL) injuries occur at a 2 to 10-fold greater rate in female than male athletes.
Consequently, there is a larger population of females that endure significant pain, functional limitations, and radiographic signs of knee osteoarthritis (OA) within 12 to 20 years following injury.
To reduce the burden of OA, The National Public Health Agenda for Osteoarthritis recommends expanding and refining evidence-based prevention of ACL injury.
Specialized training that targets modifiable risk factors shows statistical efficacy in high-risk athletes; however, clinically meaningful reduction of risk has not been achieved.
A critical barrier that limits successful training outcomes is the requirement of qualified instructors to deliver personalized, intuitive, and accessible feedback to young athletes.
Thus, a key gap in knowledge is how to efficiently deliver objective, effective feedback during training for injury prevention.
The investigators long-term goal is to reduce ACL injuries and the subsequent sequela in young female athletes.
The overall objective of this proposal is to implement and test innovative augmented neuromuscular training (aNMT) techniques to enhance sensorimotor learning and reduce biomechanical risk factors for ACL injury.
The rationale that underlies this proposal is that, after completion, the investigators will be equipped to more effectively deliver biofeedback and decelerate the trend of increasing ACL injury rates in female athletes.
This contribution will be significant for the reduction of the long-term sequel following ACL injury in young females.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Augmented neuromuscular training (aNMT) integrates biomechanical screening with state-of-the-art augmented reality headsets to display real-time feedback that maps complex biomechanical variables onto simple visual feedback stimuli that athletes "control" via their own movements.
The central hypothesis is that aNMT biofeedback will improve joint mechanics in evidence-based measures collected in realistic, sport-specific virtual reality scenarios.
Specifically, the purpose of this investigation is to determine the efficacy of aNMT biofeedback to improve high-risk landing mechanics both in a laboratory task and during sport-specific scenarios.
Based on the investigator's preliminary data, the investigators hypothesize that aNMT biofeedback will produce greater improvements in localized joint mechanics compared to neuromuscular training that incorporates sham feedback during the drop vertical jump (DVJ) task.
In the secondary Aim, the investigators hypothesize aNMT will produce improved localized joint mechanics and global injury risk techniques during sport-specific maneuvers assessed in immersive virtual environments compared to the sham feedback.
The expected outcomes will support increased efficiency and enhanced efficacy of feedback for personalized and targeted injury prevention training.
The positive impact will be the improvement of injury risk mechanics and the potential to reduce injury on the field of play.
A randomized, repeated-measures design will be used to test the two hypotheses for Aim 1: First, that aNMT will produce greater improvements in localized joint mechanics compared to the sham feedback group during the DVJ task; second, based on the preliminary data the investigators expect that innovative aNMT will lead to graduated joint improvements and reduced global injury risk mechanics that will exceed the overall task transferred reductions in high risk biomechanics following 12 real-time biofeedback training sessions.
Previously described techniques will be used to measure biomechanical risk factors during a DVJ task performed at the beginning and end of the 6-week pre-competition training period.
Athletes will be randomized into one of two groups: 1) aNMT biofeedback or (2) sham (augmented reality glasses with a stimulus that will provide exercise repetition count).
Each athlete, as well as the statisticians, will be blinded to the intervention.
All athletes will receive 12 training sessions over a 6-week period during their pre-competition season and each of the groups will have longitudinal assessment of biomechanical outcome measures captured at each biofeedback session.
All participants will complete pre-training testing, 6 weeks of intervention, post-training testing, and post-season testing.
Study Type
Interventional
Enrollment (Actual)
420
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Flowery Branch, Georgia, United States, 30542
- Emory Healthcare Sports Performance And Research Center (SPARC)
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Childrens Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- intend to participate on an organized competitive sports team (volleyball, soccer, or basketball)
- be physically able to participate in their sport and complete the testing procedures at the time of study enrollment
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: aNMT Biofeedback
Participants randomized to receive a neuromuscular training intervention that incorporates biofeedback training.
|
aNMT utilizes well-established visual feedback strategies to promote efficient, rapid and robust learning of complex movements.
Athletes can discover how to move to create the desired feedback, even without explicit, conscious knowledge of how their movements relate to the visual pattern.
aNMT biofeedback is created by calculating kinematic and kinetic data in real-time from the athlete's own movements.
These values determine real-time transformations of the stimulus shape the athlete views via augmented-reality (AR) glasses during movement performance.
The athlete's task is to move so as to create ("animate") a particular stimulus shape that corresponds to desired values of the biomechanical parameters targeted by the intervention.
Participants will complete a 12-session, pre-season training program, over 6 weeks.
|
|
Sham Comparator: Sham Biofeedback
Participants randomized to receive a neuromuscular training intervention with sham feedback training.
|
Sham biofeedback provides a similar phenomenological experience to aNMT biofeedback for athletes-both groups experience a shape that changes with their movements-but the sham biofeedback will not provide usable information to modify movement parameters during critical movement phases.
Participants will complete a 12-session, pre-season training program, over 6 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Lateral Trunk Flexion
Time Frame: Baseline (pre-training testing), Week 6 (post-training testing)
|
Lateral trunk flexion during the vertical drop task will be compared between study arms.
Optimal lateral trunk flexion is 0°.
|
Baseline (pre-training testing), Week 6 (post-training testing)
|
|
Change in Knee to Hip Sagittal Plane Moment Ratio
Time Frame: Baseline (pre-training testing), Week 6 (post-training testing)
|
Knee to hip sagittal plane moment ratio during the vertical drop task will be compared between study arms.
Optimal knee to hip sagittal plane ratio is < 1.
|
Baseline (pre-training testing), Week 6 (post-training testing)
|
|
Change in Knee Abduction Moment
Time Frame: Baseline (pre-training testing), Week 6 (post-training testing)
|
Knee abduction moment during the vertical drop task will be compared between study arms.
Optimal knee abduction moment is ≤ 0 newton meter (Nm).
|
Baseline (pre-training testing), Week 6 (post-training testing)
|
|
Change in Foot Placement
Time Frame: Baseline (pre-training testing), Week 6 (post-training testing)
|
Foot placement during the vertical drop task will be compared between study arms.
Optimal foot placement is 1:1 ratio to hip width.
|
Baseline (pre-training testing), Week 6 (post-training testing)
|
|
Change in Vertical Ground Reaction Force (VGRF) Ratio
Time Frame: Baseline (pre-training testing), Week 6 (post-training testing)
|
VGRF during the vertical drop task will be compared between study arms.
Optimal VGRF ratio is 1:1 ratio between limbs.
|
Baseline (pre-training testing), Week 6 (post-training testing)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Post-training Lateral Trunk Flexion
Time Frame: Week 6 (post-training testing), up to Month 11 (post-season testing)
|
Retention of effects of the intervention is assessed with lateral trunk flexion during the vertical drop task will be compared between study arms.
Optimal lateral trunk flexion is 0°.environments compared to the sham feedback.
The expected outcomes will support increased efficiency and enhanced efficacy of feedback for personalized and targeted injury prevention training.
|
Week 6 (post-training testing), up to Month 11 (post-season testing)
|
|
Change in Post-training Knee to Hip Sagittal Plane Moment Ratio
Time Frame: Week 6 (post-training testing), up to Month 11 (post-season testing)
|
Retention of effects of the intervention is assessed with knee to hip sagittal plane moment ratio during the vertical drop task will be compared between study arms.
Optimal knee to hip sagittal plane ratio is < 1.
|
Week 6 (post-training testing), up to Month 11 (post-season testing)
|
|
Change in Post-training Knee Abduction Moment
Time Frame: Week 6 (post-training testing), up to Month 11 (post-season testing)
|
Retention of effects of the intervention is assessed with knee abduction moment during the vertical drop task will be compared between study arms.
Optimal knee abduction moment is ≤ 0 newton meter (Nm).
|
Week 6 (post-training testing), up to Month 11 (post-season testing)
|
|
Change in Post-training Foot Placement
Time Frame: Week 6 (post-training testing), up to Month 11 (post-season testing)
|
Retention of effects of the intervention is assessed with foot placement during the vertical drop task will be compared between study arms.
Optimal foot placement is 1:1 ratio to hip width.
|
Week 6 (post-training testing), up to Month 11 (post-season testing)
|
|
Change in Post-training Vertical Ground Reaction Force (VGRF) Ratio
Time Frame: Week 6 (post-training testing), up to Month 11 (post-season testing)
|
Retention of effects of the intervention is assessed with VGRF during the vertical drop task will be compared between study arms.
Optimal VGRF ratio is 1:1 ratio between limbs.
|
Week 6 (post-training testing), up to Month 11 (post-season testing)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gregory D Myer, PhD, Emory University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
May 9, 2022
Study Completion (Actual)
May 30, 2022
Study Registration Dates
First Submitted
March 7, 2016
First Submitted That Met QC Criteria
October 11, 2016
First Posted (Estimated)
October 14, 2016
Study Record Updates
Last Update Posted (Actual)
September 19, 2024
Last Update Submitted That Met QC Criteria
September 11, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00001770
- 2014-2946 (Other Grant/Funding Number: Cincinnati Children's Hospital Medical Center)
- 5U01AR067997 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
While study results will be published, individual subject data will not be shared with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Injury of Anterior Cruciate Ligament
-
University of California, San FranciscoArthritis FoundationCompletedAcute Injury of Anterior Cruciate LigamentUnited States
-
Lynn Snyder-MacklerCompletedAcute Injury of Anterior Cruciate LigamentUnited States
-
Universidad de GranadaCompletedAcute Injury of Anterior Cruciate LigamentSpain
-
Bergen Knee GroupCompletedInjury of Anterior Cruciate Ligament | Deficiency of Anterior Cruciate LigamentNorway
-
University of CalgaryWorkers' Compensation Board, AlbertaCompletedAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Injury | Chronic Instability of Knee | Deficiency of Anterior Cruciate LigamentCanada
-
University of ManitobaCompletedInjury of Anterior Cruciate LigamentCanada
-
The Hawkins FoundationCompleted
-
Alexander Rofner-MorettiRecruitingAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament InjuryAustria
-
ASST Gaetano Pini-CTOCompletedInjury of Anterior Cruciate LigamentItaly
-
eMKa MED Medical CenterWroclaw Medical UniversityRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Knee Injuries | Knee Ligament InjuryPoland
Clinical Trials on aNMT Biofeedback
-
Emory UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedAnterior Cruciate Ligament InjuriesUnited States
-
Klick Inc.Completed
-
L. Eugene ArnoldNational Institute of Mental Health (NIMH); Brain Resource CenterCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Technische Universität DresdenMichael J. Fox Foundation for Parkinson's Research; University Hospital Carl...CompletedAutonomic Dysfunction | Acute Ischaemic StrokeGermany
-
Badr UniversityCompletedFecal Incontinence in ChildrenEgypt
-
The Hong Kong Polytechnic UniversityKwong Wah HospitalCompleted
-
Icahn School of Medicine at Mount SinaiCompletedMajor Depressive DisorderUnited States
-
New York UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Syracuse... and other collaboratorsCompletedSpeech Sound DisorderUnited States
-
Rutgers, The State University of New JerseyArthritis FoundationCompleted
-
Prof. Dr. med. Arno FriggSuspendedComplication of Surgical or Medical CareSwitzerland